Sustained release pharmaceutical oral solid dosage forms of dronedarone or one of its pharmaceutically acceptable salts

摘要

The instant invention relates to a sustained release pharmaceutical oral solid dosage form comprising a therapeutically effective amount of dronedarone or pharmaceutically acceptable salts thereof adapted to release over a predetermined time period according to a profile of dissolution characterized in that the total amount of dronedarone or pharmaceutically acceptable salts thereof is liberated at 240 minutes. Preparation and application in therapeutics.